Press releases & news

 

2018-10-09

Press releases regulatory

2cureX announces CE-IVD marking of its IndiTreat test

2cureX AB (“2cureX”), a leading company in conducting individual treatment design of cancer patients, is pleased to announce the receival...

2018-08-24

Press releases regulatory

2cureX AB publishes interim report for the first half-year of 2018

2cureX AB (”2cureX”) hereby publishes the interim report for the first half-year of 2018. The interim report is available via...

2018-08-22

Press releases regulatory

2cureX strengthen its patent portfolio with the granting of a new European patent

2cureX AB (“2cureX”) is pleased to announce the grant of European patent No. 3164709 “Identifying compounds modifying a cellular phenotype”....

2018-06-21

Press releases regulatory

2cureX presents positive clinical data from its IndiTreat® CRC trial at ESMO in Barcelona

2cureX AB (“2cureX”) today announces that the company will present positive data from the IndiTreat® clinical validation trial within colorectal...

2018-05-29

Press releases regulatory

Clarification of warrants resolved at the Annual General Meeting

Yesterday, on May 28, 2018, the Annual General Meeting was held in 2cureX AB (publ). The company hereby publishes a...

2018-05-29

Press releases regulatory

Communication from the Annual General Meeting (Swedish)

Idag, den 28 maj 2018, hölls årsstämma 2cureX AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...

« Older news

Contact information

Laboratory: 2cureX, Building 8, 2. Tværvej, Bispebjerg Bakke 23, 2400 Copenhagen NV, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint